Beraprost sodium salt
98%
- Product Code: 107778
CAS:
88475-69-8
| Molecular Weight: | 420.5 g./mol | Molecular Formula: | C₂₄H₂₉O₅Na |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Beraprost sodium salt is primarily used in the treatment of pulmonary arterial hypertension (PAH). It works by dilating blood vessels and inhibiting platelet aggregation, which helps to reduce blood pressure in the lungs and improve blood flow. This medication is particularly beneficial for patients experiencing symptoms like shortness of breath, fatigue, and chest pain due to PAH. Additionally, it is sometimes used in the management of chronic arterial occlusion and other vascular disorders to enhance circulation and prevent complications. Its vasodilatory and antiplatelet properties make it a valuable therapeutic option for improving cardiovascular health in specific patient populations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Pale Yellow Solid |
| Purity (%) | 97.5-100 |
| Melting Point | 110 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $1,318.55 |
+
-
|
Beraprost sodium salt
Beraprost sodium salt is primarily used in the treatment of pulmonary arterial hypertension (PAH). It works by dilating blood vessels and inhibiting platelet aggregation, which helps to reduce blood pressure in the lungs and improve blood flow. This medication is particularly beneficial for patients experiencing symptoms like shortness of breath, fatigue, and chest pain due to PAH. Additionally, it is sometimes used in the management of chronic arterial occlusion and other vascular disorders to enhance circulation and prevent complications. Its vasodilatory and antiplatelet properties make it a valuable therapeutic option for improving cardiovascular health in specific patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :